Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.30 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.30 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.30 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12922157 | 0.96 | TDP1 (0.33) | CHRNB2CHRNA5CHRNA7CHRNA4 | |
| SCHEMBL978568 | 0.93 | — | — | |
| SCHEMBL6873037 | 0.90 | MGLL (0.33) | — | |
| SCHEMBL5565022 | 0.89 | POLB (0.35) | CHRNB2CHRNA5CHRNA7CHRNA4 | |
| SCHEMBL976412 | 0.89 | TDP1 (0.33) | — | |
| SCHEMBL974390 | 0.88 | TDP1 (0.32) | — | |
| SCHEMBL977736 | 0.88 | TDP1 (0.32) | — | |
| SCHEMBL974726 | 0.88 | MGLL (0.32) | — | |
| SCHEMBL13715639 | 0.88 | NPC1 (0.35) | CHRNB2CHRNA5CHRNA7CHRNA4 | |
| SCHEMBL977031 | 0.87 | TDP1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070173570-A1 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization | FUSO FRANCESCO | 2007-07-26 | — | — | US | claimed |
| EP-1341763-B1 | N-ALKOXY-4,4-DIOXY-POLYALKYL-PIPERIDINE COMPOUNDS, WITH GLYCIDYL OR ALKYLCARBONYL GROUPS AS FUNCTIONAL INITIATORS FOR CONTROLLED RADICAL POLYMERIZATION | CIBA SC HOLDING AG (CH) | 2004-06-16 | — | — | EP | claimed |
| US-20040049043-A1 | N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization | CIBA SPECIALTY CHEMICALS CORP. | 2004-03-11 | — | — | US | claimed |
| US-7868171-B2 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidines as radical polymerization initiators | CIBA SPECIALTY CHEMICALS CORP. (US) | 2011-01-11 | — | — | US | disclosed |
| US-7868171-B2 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidines as radical polymerization initiators | CIBA SPECIALTY CHEMICALS CORP. (US) | 2011-01-11 | — | — | US | disclosed |
| US-7868171-B2 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidines as radical polymerization initiators | CIBA SPECIALTY CHEMICALS CORP. (US) | 2011-01-11 | — | — | US | disclosed |
| US-20070173570-A1 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization | FUSO FRANCESCO | 2007-07-26 | — | — | US | disclosed |
| US-20070173570-A1 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization | FUSO FRANCESCO | 2007-07-26 | — | — | US | disclosed |
| US-7235663-B2 | N-alkoxy-4,4-dioxy-polyalkyl-piperidines as radical polymerization inhibitors | CIBA SPECIALTY CHEMICALS CORP. (US) | 2007-06-26 | — | — | US | disclosed |
| US-7235663-B2 | N-alkoxy-4,4-dioxy-polyalkyl-piperidines as radical polymerization inhibitors | CIBA SPECIALTY CHEMICALS CORP. (US) | 2007-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070173570-A1 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization | PTGER4, ALKBH3, PIGO | CHRNB2 3032/4885CHRNA5 1494/4885CHRNA7 2037/4885 |
| US-20040049043-A1 | N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization | PAOX, ALKBH3, PTGER4 | CHRNB2 3232/4885CHRNA5 1811/4885CHRNA7 2220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.